These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 29373239)
1. Sorafenib and fluvastatin synergistically alleviate hepatic fibrosis via inhibiting the TGFβ1/Smad3 pathway. Cheng Y; Zheng H; Wang B; Xu W; Xu J; Zhu Y Dig Liver Dis; 2018 Apr; 50(4):381-388. PubMed ID: 29373239 [TBL] [Abstract][Full Text] [Related]
2. Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells. Chong LW; Hsu YC; Lee TF; Lin Y; Chiu YT; Yang KC; Wu JC; Huang YT BMC Gastroenterol; 2015 Feb; 15():22. PubMed ID: 25886887 [TBL] [Abstract][Full Text] [Related]
3. Astaxanthin prevents TGFβ1-induced pro-fibrogenic gene expression by inhibiting Smad3 activation in hepatic stellate cells. Yang Y; Kim B; Park YK; Koo SI; Lee JY Biochim Biophys Acta; 2015 Jan; 1850(1):178-85. PubMed ID: 25450180 [TBL] [Abstract][Full Text] [Related]
4. Synergistic anti-tumor efficacy of sorafenib and fluvastatin in hepatocellular carcinoma. Cheng Y; Luo R; Zheng H; Wang B; Liu Y; Liu D; Chen J; Xu W; Li A; Zhu Y Oncotarget; 2017 Apr; 8(14):23265-23276. PubMed ID: 28423574 [TBL] [Abstract][Full Text] [Related]
5. STAT3-mediated attenuation of CCl4-induced mouse liver fibrosis by the protein kinase inhibitor sorafenib. Deng YR; Ma HD; Tsuneyama K; Yang W; Wang YH; Lu FT; Liu CH; Liu P; He XS; Diehl AM; Gershwin ME; Lian ZX J Autoimmun; 2013 Oct; 46():25-34. PubMed ID: 23948302 [TBL] [Abstract][Full Text] [Related]
6. Sorafenib ameliorates renal fibrosis through inhibition of TGF-β-induced epithelial-mesenchymal transition. Jia L; Ma X; Gui B; Ge H; Wang L; Ou Y; Tian L; Chen Z; Duan Z; Han J; Fu R PLoS One; 2015; 10(2):e0117757. PubMed ID: 25679376 [TBL] [Abstract][Full Text] [Related]
7. Combination of sorafenib and gadolinium chloride (GdCl3) attenuates dimethylnitrosamine(DMN)-induced liver fibrosis in rats. Liu C; Yang Z; Wang L; Lu Y; Tang B; Miao H; Xu Q; Chen X BMC Gastroenterol; 2015 Nov; 15():159. PubMed ID: 26572488 [TBL] [Abstract][Full Text] [Related]
8. E-cadherin antagonizes transforming growth factor β1 gene induction in hepatic stellate cells by inhibiting RhoA-dependent Smad3 phosphorylation. Cho IJ; Kim YW; Han CY; Kim EH; Anderson RA; Lee YS; Lee CH; Hwang SJ; Kim SG Hepatology; 2010 Dec; 52(6):2053-64. PubMed ID: 20890948 [TBL] [Abstract][Full Text] [Related]
9. Salvianolic acid B inhibits hepatic stellate cell activation through transforming growth factor beta-1 signal transduction pathway in vivo and in vitro. Tao YY; Wang QL; Shen L; Fu WW; Liu CH Exp Biol Med (Maywood); 2013 Nov; 238(11):1284-96. PubMed ID: 24006304 [TBL] [Abstract][Full Text] [Related]
10. Antifibrotic activity of sorafenib in experimental hepatic fibrosis: refinement of inhibitory targets, dosing, and window of efficacy in vivo. Hong F; Chou H; Fiel MI; Friedman SL Dig Dis Sci; 2013 Jan; 58(1):257-64. PubMed ID: 22918681 [TBL] [Abstract][Full Text] [Related]
11. Pin1 induction in the fibrotic liver and its roles in TGF-β1 expression and Smad2/3 phosphorylation. Yang JW; Hien TT; Lim SC; Jun DW; Choi HS; Yoon JH; Cho IJ; Kang KW J Hepatol; 2014 Jun; 60(6):1235-41. PubMed ID: 24530597 [TBL] [Abstract][Full Text] [Related]
12. Fluvastatin decreases cardiac fibrosis possibly through regulation of TGF-beta(1)/Smad 7 expression in the spontaneously hypertensive rats. Zhai Y; Gao X; Wu Q; Peng L; Lin J; Zuo Z Eur J Pharmacol; 2008 Jun; 587(1-3):196-203. PubMed ID: 18430418 [TBL] [Abstract][Full Text] [Related]
13. Distinct antifibrogenic effects of erlotinib, sunitinib and sorafenib on rat pancreatic stellate cells. Elsner A; Lange F; Fitzner B; Heuschkel M; Krause BJ; Jaster R World J Gastroenterol; 2014 Jun; 20(24):7914-25. PubMed ID: 24976727 [TBL] [Abstract][Full Text] [Related]
14. Fluvastatin inhibits high glucose-induced nuclear factor kappa B activation in renal tubular epithelial cells. Gao P; Wu X; Shui H; Jia R J Nephrol; 2013; 26(2):289-96. PubMed ID: 22641573 [TBL] [Abstract][Full Text] [Related]
15. Fluvastatin enhances sorafenib cytotoxicity in melanoma cells via modulation of AKT and JNK signaling pathways. Zhang S; Doudican NA; Quay E; Orlow SJ Anticancer Res; 2011 Oct; 31(10):3259-65. PubMed ID: 21965734 [TBL] [Abstract][Full Text] [Related]
16. New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis. Wang Y; Gao J; Zhang D; Zhang J; Ma J; Jiang H J Hepatol; 2010 Jul; 53(1):132-44. PubMed ID: 20447716 [TBL] [Abstract][Full Text] [Related]
17. Curcumin inhibits TGFβ1-induced CCN2 via Src, JNK, and Smad3 in gingiva. Yang WH; Kuo MY; Liu CM; Deng YT; Chang HH; Chang JZ J Dent Res; 2013 Jul; 92(7):629-34. PubMed ID: 23609161 [TBL] [Abstract][Full Text] [Related]
18. Levistilide A inhibits angiogenesis in liver fibrosis via vascular endothelial growth factor signaling pathway. Zhao ZM; Liu HL; Sun X; Guo T; Shen L; Tao YY; Liu CH Exp Biol Med (Maywood); 2017 May; 242(9):974-985. PubMed ID: 28440736 [TBL] [Abstract][Full Text] [Related]
19. [Adiponectin inhibits the activation of hepatic stellate cells induced by TGFb1 via up-regulating the expression of eNOS]. Wang W; Zhao CY; Wang YD; He X; Shen C; Cao W; Zhou JY; Zhen Z Zhonghua Gan Zang Bing Za Zhi; 2011 Dec; 19(12):917-22. PubMed ID: 22525505 [TBL] [Abstract][Full Text] [Related]
20. Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial-mesenchymal transition and fibroblast activation. Chen YL; Zhang X; Bai J; Gai L; Ye XL; Zhang L; Xu Q; Zhang YX; Xu L; Li HP; Ding X Cell Death Dis; 2013 Jun; 4(6):e665. PubMed ID: 23764846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]